Selected Reviews of AAO 2011 Retina SubSpecialty Day Presentations
Here is another overview of a presentation made during the Retina SubSpecialty Day Meeting.
Dr. Elias Reichel, of Tufts University School of Medicine and a founder of Hemera Biosciences, Inc., of Boston, MA, presented on a new approach to treating the dry form of age-related macula degeneration. His paper was based on the research being done by Hemera Biosciences on HMR59, a naturally occurring protein that protects retinal cells from damage by MAC (Membrane Attack Complex), that can be delivered for long-lasting activity via a gene therapy approach.
HMR59 was developed (Read more...)